Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$239.25 - $280.76 $4 Million - $4.69 Million
16,700 Added 53.18%
48,100 $13.4 Million
Q2 2024

Aug 14, 2024

SELL
$235.51 - $267.98 $15.3 Million - $17.4 Million
-65,000 Reduced 67.43%
31,400 $7.85 Million
Q1 2024

May 14, 2024

BUY
$224.58 - $256.19 $5.57 Million - $6.35 Million
24,800 Added 34.64%
96,400 $24.1 Million
Q4 2023

Feb 13, 2024

BUY
$185.1 - $233.13 $8.22 Million - $10.4 Million
44,400 Added 163.24%
71,600 $16.6 Million
Q3 2023

Nov 13, 2023

SELL
$233.08 - $265.59 $7.6 Million - $8.66 Million
-32,600 Reduced 54.52%
27,200 $6.75 Million
Q2 2023

Aug 14, 2023

BUY
$224.99 - $256.14 $13.5 Million - $15.3 Million
59,800 New
59,800 $14.4 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $167B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.